SEC Filing Analysis: Revolution Medicines, Inc. (RVMD)

Executive Summary

• Trading Significance: Low
• Key Takeaway: COO Margaret Horn sold shares solely to cover tax withholding obligations related to RSU vesting.
• Market Impact: Neutral - This is an administrative transaction with no bearish sentiment signal.

Company Information

Field	Value
Company	Revolution Medicines, Inc.
Ticker Symbol	RVMD
CIK	0001628171
Industry	Biological Products

Insider Information

Field	Value
Name	Horn Margaret A
CIK	0001294192
Title/Position	Chief Operating Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-03-17
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	4,583
Price Per Share	$99.48
Total Value	$455,919
Shares Owned After	157,570
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$455,919
% of Market Cap	0.0024%
Shares Transacted	4,583
% of Shares Outstanding	0.0023%
Post-Transaction Ownership	157,570 (0.08% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market cap of $18.80 billion, a $456k transaction is statistically irrelevant to the stock price.
• Ownership Concentration: The insider retains a significant position of over 157k shares following this sale.
• Transaction Significance: The transaction represents less than 0.01% of both market cap and shares outstanding, placing it well below the threshold for market significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The filing footnotes explicitly state this sale was to satisfy tax withholding obligations ("sell-to-cover") and was done under a 10b5-1 plan. This is a routine administrative action, not a discretionary exit.

Volume & Sentiment

• Expected Volume Impact: None.
• Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

• Special Circumstances: The sale was conducted pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023. The specific purpose was to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs).